Related Experiment Video
Updated: Aug 6, 2026

06:34
Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
Electromechanical Profiling in Genotyped Dilated Cardiomyopathy with Left Bundle Branch Block
Thomas Van Overmeiren1, Lorenzo Bianchi2,3, Max F G H M Venner2,3
1Department of Cardiology, Ghent University Hospital, Ghent, Belgium.
European Journal of Heart Failure
|July 22, 2026
Summary
Genetic testing in dilated cardiomyopathy (DCM) with left bundle branch block (LBBB) has low yield. Genotype-positive patients show distinct electromechanical profiles, poor cardiac resynchronization therapy (CRT) response, and worse outcomes.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Dilated cardiomyopathy (DCM) management often includes genetic testing.
- Left bundle branch block (LBBB) in DCM patients presents unique diagnostic and therapeutic challenges.
- The interplay between genetic variants, LBBB characteristics, and treatment response in DCM is not fully understood.
Purpose of the Study:
- To investigate the prevalence and impact of pathogenic/likely pathogenic (P/LP) variants in DCM patients with LBBB.
- To analyze the electromechanical profile of genotyped DCM patients with LBBB.
- To determine the relationship between genetic status, electromechanical parameters, cardiac resynchronization therapy (CRT) response, and clinical outcomes.
Main Methods:
- A multicenter cohort of 347 DCM patients with LBBB undergoing genetic testing was analyzed.
- Comprehensive electro- and echocardiographic phenotyping, including speckle-tracking strain analysis, was performed.
- CRT response was assessed by changes in end-systolic volume (ESV) and left ventricular ejection fraction (LVEF).
Main Results:
- Only 6% of DCM patients with LBBB carried P/LP variants.
- Genotype-positive patients displayed atypical LBBB features and reduced mechanical dyssynchrony.
- These patients showed poorer CRT response and worse clinical outcomes (mortality, heart failure hospitalization).
Conclusions:
- Genetic testing has limited diagnostic utility in DCM patients with LBBB.
- A distinct electromechanical profile in genotype-positive DCM with LBBB is associated with suboptimal CRT response and adverse prognosis.
- Combined genetic and electromechanical phenotyping may enhance risk stratification and personalized treatment strategies.
Keywords:
Dilated cardiomyopathycardiac resynchronization therapygenetic testingleft bundle branch blockstrain imaging
